comprehensive -WSS

comprehensive

author：leisure time 2025-10-01 00:49:52 - browse：5575

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Histogen: Failed biotech offers rare public look inside

focus

WSS

FDA panel signals lack of confidence in Amgen cancer drug data

Stroke deaths set to near 10 million globally by 2050

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

5 ways to address the shortage of health care workers

CDC advisory group OKs chikungunya vaccine

Bill would stop addiction treatment from triggering child abuse inquiry

Wikipedia

comprehensive

leisure time

Anesthesiologist group: stop taking Ozempic before surgery

Liquid biopsy for lung cancer is launched by Delfi

Cancer drug shortages should be causing more outrage

AI can decode, harness the power of the humane immune system

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Change Healthcare cyberattack shows risk of industry consolidation

Virginia high school admissions case could be legal follow

Why age limits for politicians are a terrible idea

Activists slam private health insurers over coverage restrictions

When women are denied an abortion, their children fare worse than peers

Wikipedia

Senate panel eyes new effort on drug shortages

Cholera vaccine supplies dangerously low, outbreaks surging

Why Charlie Gard's case is so disturbing to Americans

AI can decode, harness the power of the humane immune system

Laying a path for careers in science

3 questions for the future of Biden's cancer moonshot

explore

hotspot

focus

hotspot